These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2754357)

  • 21. [Treatment of acute thrombophlebitis of the lower limbs with long-term intraosseous drug infusions].
    Mel'nik VM
    Vestn Khir Im I I Grek; 1979 Nov; 123(11):64-6. PubMed ID: 524666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
    Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of intravenous electrodes of cardiac pacemakers. Clinical and plethysmographic approach].
    Glock Y; Salvador-Mazenq M; Boccalon H; Vaislic C; Puel P
    Phlebologie; 1985; 38(4):599-607. PubMed ID: 4095148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
    Lévesque H; Cailleux N; Vasse D; Legallicier B; Moore N; Borg JY; Hantute N; Thuillez C; Courtois H
    Therapie; 1994; 49(2):101-5. PubMed ID: 7817331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the medical treatment of deep vein thrombosis.
    Schulman S
    Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Unusual cause of leg venous thrombosis in a 20-year-old man].
    Ziegler T; Winkler C
    Wien Klin Wochenschr; 2000 Dec; 112(24):1039. PubMed ID: 11204313
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment concept in deep pelvic-leg venous thrombosis].
    Gloor B; Müller M; Largiadèr J
    Swiss Surg; 1996; (3):78-86, discussion 86-7. PubMed ID: 8681121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sequelae of deep venous thrombosis, 5-year follow-up of 341 patients].
    Widmer MT; Zemp E; Voëlin R; Brandenberg E; Da Silva A
    Phlebologie; 1987; 40(4):915-21. PubMed ID: 3447194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the obstructive factor and its importance in the caval and ilio-caval postphlebitic syndrome].
    Mourette I
    Phlebologie; 1987; 40(3):681-709. PubMed ID: 2960993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. A prospective study.
    Kakkar VV; Lawrence D
    Am J Surg; 1985 Oct; 150(4A):54-63. PubMed ID: 4051122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute superficial thrombophlebitis--therapeutic strategies].
    Noppeney T; Noppeney J; Winkler M; Kurth I
    Zentralbl Chir; 2006 Feb; 131(1):51-6. PubMed ID: 16485211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Venous hemodynamics in axillary venous stasis].
    Joel A; Voigt H
    Z Gesamte Inn Med; 1988 Oct; 43(20):592-3. PubMed ID: 3213121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In situ thrombolysis in the treatment of venous thrombosis of effort in the arm].
    Pegis JD; Papon X; Pasco A; Regnard O; Abraham P; Enon B
    J Mal Vasc; 1997 Jul; 22(3):187-92. PubMed ID: 9303935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin treatment of deep venous thrombosis without venography.
    Good AE
    Ann Intern Med; 1981 Oct; 95(4):515. PubMed ID: 7283309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.